In one cohort, TRAF6 expression was higher in the tumor than surrounding tissues in 59.6% of the patients and was inversely related to chemo-sensitivity, but unrelated to cancer stages or overall survival (Liu et al., 2012). Here, TRAF6 is linked to neoplasm.